Drug recall · April 15, 2020
nICARdipine HCl recall
Why: Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-01
- Lots / codes
193540006D, Exp 3/22/2020
- Quantity
- 80 units
- Company
- PharMEDium Services, LLC, Dayton, NJ
- Distribution
- Distributed Nationwide in the US
- Initiated
- March 16, 2020 · Voluntary: Firm initiated
- Classified
- April 6, 2020
- Reported
- April 15, 2020
- Ended
- February 14, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nicardipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.